Clinical Trial Update: Losartan for Sickle Cell Kidney Disease [EARLY_Phase 1]

View source ↗

Summary

This update reports the completion of an early-phase (Phase 1) trial evaluating losartan for sickle cell kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Sickle Cell Nephropathy

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Emory University | Conditions: Sickle Cell Disease | EARLY_Phase 1 | Status: COMPLETED